LOU SILVERMAN

CIK 1249935 · Chief Executive Officer · last filed 2026-06-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$802.8K

Companies

4

Total Filings

38

Lifetime Open-Market Net

-$6.86M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Insight Molecular Diagnostics Inc. (OCX) Delisted Director 36,564 $3.20 $117.0K $0 3 2025-07-03
STAA Director 4,424 $28.37 $125.5K -$6.86M 15 2025-06-20
BTX Director 75,000 $9.03 $677.2K $0 4 2016-10-31
QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Director 14,183 $0 8 2013-05-29

Recent Filings · Page 4 of 4

38 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2010-07-16 QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Grant (A) $0 EDGAR
2010-06-02 QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Grant (A) $0 EDGAR
2010-01-04 QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Grant (A) $0 EDGAR
2009-12-11 QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Grant (A) $0 EDGAR
2008-06-20 Exer (M) +42,500 $821.8K
2007-06-13 Mixed +2,700 -$1.57M
2007-06-13 Sell (S) −2,700 -$103.6K
2007-06-13 Grant (A) $0
Showing 3138 of 38
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.